Amin Jalilvand
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Amin Jalilvand has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Nazanin Karimi
Infertility Treatment Center, ACECR, Kermanshah, Iran
3 shared publications- Kheirollah Yari
Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
2 shared publications Amirhosein Meisami
Emergency Medicine Kermanshah University of Medical Sciences Kermanshah Iran
1 shared publicationFatemeh Heydarpour
Social Development and Health Promotion Research Center, Health institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
1 shared publicationIman Salahshouri Far
Department of Biology, Science and Research Branch Islamic Azad University Tehran Iran
1 shared publicationKheirollah Yari
Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
1 shared publication
Latest Publications
- 5 January 2026
- Published by Springer Nature in 3 Biotech
- Vol. 16 (1) , 44
Microarray analysis for transcriptomic profiling in neuroscience: uncovering key molecular mechanisms and candidate biomarkers in Alzheimer’s disease
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that leads to cognitive decline, memory loss, and neuronal damage. Advances in high-throughput technologies, such as microarrays, have significantly enhanced our understanding of complex diseases by enabling large-scale gene expression analysis. This study explores differentially expressed genes (DEGs), key hub genes, and dysregulated pathways in AD using the GSE118553 dataset, aiming to uncover potential biomarkers and therapeutic targets. Gene expression data from AD and control brain tissues were analyzed to identify DEGs. A protein-protein interaction (PPI) network was constructed to determine hub genes, followed by subnetwork and co-expression analyses. Functional enrichment analysis, including Gene Set Enrichment Analysis (GSEA), was performed to examine the biological pathways involved in AD. A total of 108 DEGs were identified, including 79 upregulated and 29 downregulated genes. Among these, 15 hub genes (FOS, CD44, THBS1, CCL2, HSPA1A, HSPA1B, FGF2, COL6A3, KLF4, CD74, DNAJB1, HSPA6, SPARC, YAP1, and BAG3) were significantly dysregulated. Functional enrichment analysis revealed key pathways related to heat acclimation, inclusion body regulation, and protein homeostasis. Additionally, potential therapeutic strategies were proposed to target these pathways and slow AD progression. This study identified crucial hub genes and dysregulated pathways in AD, with COL6A3 and BAG3 emerging as novel candidate genes. These findings provide deeper insights into the molecular mechanisms underlying AD and suggest potential therapeutic targets. Future research should focus on validating these findings and developing targeted interventions to regulate the identified pathways.
- 5 January 2026
- Published by Springer Nature in 3 Biotech
- Vol. 16 (1) , 44
Microarray analysis for transcriptomic profiling in neuroscience: uncovering key molecular mechanisms and candidate biomarkers in Alzheimer’s disease
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that leads to cognitive decline, memory loss, and neuronal damage. Advances in high-throughput technologies, such as microarrays, have significantly enhanced our understanding of complex diseases by enabling large-scale gene expression analysis. This study explores differentially expressed genes (DEGs), key hub genes, and dysregulated pathways in AD using the GSE118553 dataset, aiming to uncover potential biomarkers and therapeutic targets. Gene expression data from AD and control brain tissues were analyzed to identify DEGs. A protein-protein interaction (PPI) network was constructed to determine hub genes, followed by subnetwork and co-expression analyses. Functional enrichment analysis, including Gene Set Enrichment Analysis (GSEA), was performed to examine the biological pathways involved in AD. A total of 108 DEGs were identified, including 79 upregulated and 29 downregulated genes. Among these, 15 hub genes (FOS, CD44, THBS1, CCL2, HSPA1A, HSPA1B, FGF2, COL6A3, KLF4, CD74, DNAJB1, HSPA6, SPARC, YAP1, and BAG3) were significantly dysregulated. Functional enrichment analysis revealed key pathways related to heat acclimation, inclusion body regulation, and protein homeostasis. Additionally, potential therapeutic strategies were proposed to target these pathways and slow AD progression. This study identified crucial hub genes and dysregulated pathways in AD, with COL6A3 and BAG3 emerging as novel candidate genes. These findings provide deeper insights into the molecular mechanisms underlying AD and suggest potential therapeutic targets. Future research should focus on validating these findings and developing targeted interventions to regulate the identified pathways.
- 1 February 2021
- Published by Hindawi Limited in Andrologia
- Vol. 53 (1) , e13633
Impact of polymorphism in DNA repair genes OGG1 and XRCC1 on seminal parameters and human male infertility
Click on the article title to read more.
- 1 February 2021
- Published by Hindawi Limited in Andrologia
- Vol. 53 (1) , e13633
Impact of polymorphism in DNA repair genes OGG1 and XRCC1 on seminal parameters and human male infertility
Click on the article title to read more.
- 1 November 2020
- Published by Elsevier in Pathology - Research and Practice
- Vol. 216 (11) , 153190
Letter to the Editor concerning: Genetic variants in HLA-DP/DQ contribute to risk of acute myeloid leukemia: A case-control study in Chinese
- 1 November 2020
- Published by Elsevier in Pathology - Research and Practice
- Vol. 216 (11) , 153190
Letter to the Editor concerning: Genetic variants in HLA-DP/DQ contribute to risk of acute myeloid leukemia: A case-control study in Chinese
- 1 October 2020
- Published by Wiley in International Journal of Immunogenetics
- Vol. 47 (5) , 454
A comment on "Association of hepatocellular carcinoma risk with polymorphisms in tumour necrosis factor alpha gene in a Chinese Han population"
- 1 October 2020
- Published by Wiley in International Journal of Immunogenetics
- Vol. 47 (5) , 454
A comment on "Association of hepatocellular carcinoma risk with polymorphisms in tumour necrosis factor alpha gene in a Chinese Han population"
- Open Access
- 20 September 2020
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 34 (12)
A case‐control study on the SNP309T → G and 40‐bp Del1518 of theMDM2gene and a systematic review forMDM2polymorphisms in the patients with breast cancer
Objective: The current research was conducted to study the association between the SNP309 and del1518 polymorphisms with the breast cancer in the patients with the Kurdish ethnic background from western Iran. Also, a systematic review of the relevant case‐control studies on theMDM2polymorphisms in the patients with breast cancer was performed.Methodology: Two mL of peripheral blood was taken from 100 patients with breast cancer and 100 healthy individuals. The frequencies ofMDM2SNP309 and del1518 genotypes and alleles were determined using the PCR‐RFLP and PCR methods, respectively.Results: The frequency of the TT, TG, and GG ofMDM2‐SNP309 genotypes in the patients was obtained as 23%, 52%, and 25%, and they were equal to 22%, 40%, and 38% in the control group, respectively. Also, considering theMDM2‐del1518 polymorphism, the frequencies of ins/ins, ins/del, and del/del genotypes were equal to 52%, 41%, and 7% in the breast cancer group and they were equal to 62, 30, and 8% in the control group, respectively. Analysis of the results indicated that the GG genotype plays a protective role for the breast cancer in the recessive model (GG vs TT + TG) of SNP309 (χ2 = 3.916,P = .048, and OR = 0.54).Conclusion: Our findings revealed that the GG genotype ofMDM2‐SNP309 can play a protective role in the breast cancer disease. Also, our systematic review indicated that the SNP309, SNP285, and del1518 ofMDM2gene in different populations mostly did not have a significant association with the risk of breast cancer.
- 20 September 2020
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 34 (12)
Open AccessA case‐control study on the SNP309T → G and 40‐bp Del1518 of theMDM2gene and a systematic review forMDM2polymorphisms in the patients with breast cancer
Objective: The current research was conducted to study the association between the SNP309 and del1518 polymorphisms with the breast cancer in the patients with the Kurdish ethnic background from western Iran. Also, a systematic review of the relevant case‐control studies on theMDM2polymorphisms in the patients with breast cancer was performed.Methodology: Two mL of peripheral blood was taken from 100 patients with breast cancer and 100 healthy individuals. The frequencies ofMDM2SNP309 and del1518 genotypes and alleles were determined using the PCR‐RFLP and PCR methods, respectively.Results: The frequency of the TT, TG, and GG ofMDM2‐SNP309 genotypes in the patients was obtained as 23%, 52%, and 25%, and they were equal to 22%, 40%, and 38% in the control group, respectively. Also, considering theMDM2‐del1518 polymorphism, the frequencies of ins/ins, ins/del, and del/del genotypes were equal to 52%, 41%, and 7% in the breast cancer group and they were equal to 62, 30, and 8% in the control group, respectively. Analysis of the results indicated that the GG genotype plays a protective role for the breast cancer in the recessive model (GG vs TT + TG) of SNP309 (χ2 = 3.916,P = .048, and OR = 0.54).Conclusion: Our findings revealed that the GG genotype ofMDM2‐SNP309 can play a protective role in the breast cancer disease. Also, our systematic review indicated that the SNP309, SNP285, and del1518 ofMDM2gene in different populations mostly did not have a significant association with the risk of breast cancer.
- Open Access
- 5 July 2020
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 34 (10) , e23436
Association of IGF‐1 gene rs2195239 polymorphism with the risk and clinical features of gastric cancer in a Chinese Han population
- 5 July 2020
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 34 (10) , e23436
Open AccessAssociation of IGF‐1 gene rs2195239 polymorphism with the risk and clinical features of gastric cancer in a Chinese Han population
- Open Access
- 1 January 2020
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 19
Corrigendum to “The Study of MDM2 rs937283 Variantand Cancer Susceptibility in a Central Chinese Population”
- 1 January 2020
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 19
Open AccessCorrigendum to “The Study of MDM2 rs937283 Variantand Cancer Susceptibility in a Central Chinese Population”